Inventor · disambiguated record
Paul Chaplin
Also filed as: CHAPLIN PAUL · CHAPLIN PAUL D
41 granted patents·10 pending applications·1,195 citations·filing 1992–2021
98Inventor score
Files withBAVARIAN NORDIC AS32CHAPLIN PAUL13HOWLEY PAUL4ATHENRY ENTERPRISES LIMITED1MCDERMOTT INT INC1
Top patents by PatentIndex Score
51 records- 0198US8268329B2Modified Vaccinia ankara virus variantCHAPLIN PAUL·Filed 2011·Granted Sep 18, 2012·28 cites·18 claims
- 0298US7939086B2Modified Vaccinia Ankara virus variantBAVARIAN NORDIC AS·Filed 2009·Granted May 10, 2011·32 cites·33 claims
- 0398US7459270B2Modified Vaccinia Ankara virus variantBAVARIAN NORDIC AS·Filed 2007·Granted Dec 2, 2008·39 cites·21 claims
- 0498US7445924B2Modified Vaccinia Ankara virus variant and cultivation methodBAVARIAN NORDIC AS·Filed 2005·Granted Nov 4, 2008·63 cites·18 claims
- 0598US7384644B2Modified Vaccinia Ankara virus variantBAVARIAN NORDIC AS·Filed 2005·Granted Jun 10, 2008·54 cites·41 claims
- 0698US7335364B2Modified Vaccinia Ankara virus variantBAVARIAN NORDIC AS·Filed 2006·Granted Feb 26, 2008·58 cites·23 claims
- 0798US6761893B2Modified vaccinia ankara virus variantBAVARIAN NORDIC AS·Filed 2003·Granted Jul 13, 2004·222 cites·34 claims
- 0897US8470598B2Modified Vaccinia Ankara virus variant and cultivation methodCHAPLIN PAUL·Filed 2012·Granted Jun 25, 2013·23 cites·20 claims
- 0997US8309098B2Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs)HOWLEY PAUL·Filed 2011·Granted Nov 13, 2012·33 cites·19 claims
- 1097US8268325B2Modified Vaccinia Ankara virus variantCHAPLIN PAUL·Filed 2011·Granted Sep 18, 2012·23 cites·20 claims
- 1197US8236560B2Modified Vaccinia Ankara virus variant and cultivation methodCHAPLIN PAUL·Filed 2011·Granted Aug 7, 2012·24 cites·20 claims
- 1297US7964396B2Modified vaccinia ankara virus variant and cultivation methodBAVARIAN NORDIC AS·Filed 2008·Granted Jun 21, 2011·30 cites·24 claims
- 1397US7964398B2Modified vaccinia ankara virus variant and cultivation methodBAVARIAN NORDIC AS·Filed 2010·Granted Jun 21, 2011·28 cites·23 claims
- 1497US7923017B2Modified Vaccinia Ankara virus variantBAVARIAN NORDIC AS·Filed 2007·Granted Apr 12, 2011·32 cites·16 claims
- 1597US6913752B2Modified Vaccinia Ankara virus variantBAVARIAN NORDIC AS·Filed 2003·Granted Jul 5, 2005·106 cites·31 claims
- 1696US8163293B2Modified Vaccinia Virus Ankara for the vaccination of neonatesCHAPLIN PAUL·Filed 2011·Granted Apr 24, 2012·30 cites·22 claims
- 1796US8021669B2Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)BAVARIAN NORDIC AS·Filed 2009·Granted Sep 20, 2011·21 cites·32 claims
- 1896US7964395B2Modified vaccinia ankara virus variant and cultivation methodBAVARIAN NORDIC AS·Filed 2008·Granted Jun 21, 2011·30 cites·8 claims
- 1996US7501127B2Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus AnkaraBAVARIAN NORDIC AS·Filed 2006·Granted Mar 10, 2009·26 cites·19 claims
- 2096US7189536B2Modified vaccinia ankara virus variantBAVARIAN NORDIC AS·Filed 2003·Granted Mar 13, 2007·56 cites·13 claims
- 2195US7628980B2Modified vaccinia virus ankara for the vaccination of neonatesBAVARIAN NORDIC AS·Filed 2005·Granted Dec 8, 2009·30 cites·11 claims
- 2295US7097842B2Modified vaccinia virus ankara for the vaccination of neonatesBAVARIAN NORDIC AS·Filed 2003·Granted Aug 29, 2006·87 cites·26 claims
- 2394US8372622B2Modified vaccinia virus ankara for the vaccination of neonatesBAVARIAN NORDIC AS·Filed 2011·Granted Feb 12, 2013·23 cites·20 claims
- 2493US8029800B2Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)BAVARIAN NORDIC AS·Filed 2009·Granted Oct 4, 2011·12 cites·32 claims
- 2593US7892533B2Modified vaccinia virus ankara for the vaccination of neonatesBAVARIAN NORDIC AS·Filed 2009·Granted Feb 22, 2011·26 cites·19 claims
- 2691US8197822B2Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)HOWLEY PAUL·Filed 2011·Granted Jun 12, 2012·6 cites·19 claims
- 2790US7897156B2Modified vaccinia virus ankara for the vaccination of neonatesBAVARIAN NORDIC AS·Filed 2008·Granted Mar 1, 2011·22 cites·12 claims
- 2887US8323661B2Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)HOWLEY PAUL·Filed 2011·Granted Dec 4, 2012·3 cites·19 claims
- 2986US8198088B2Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)HOWLEY PAUL·Filed 2011·Granted Jun 12, 2012·5 cites·18 claims
- 3085US9463238B2Recombinant poxvirus vector comprising tetanus toxin fragment CBAVARIAN NORDIC AS·Filed 2012·Granted Oct 11, 2016·3 cites·19 claims
- 3182US9265823B2Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agentsBAVARIAN NORDIC AS·Filed 2014·Granted Feb 23, 2016·2 cites·19 claims
- 3279US8808709B2Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agentsCHAPLIN PAUL·Filed 2011·Granted Aug 19, 2014·4 cites·20 claims
- 3374US10532094B2Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccineBAVARIAN NORDIC AS·Filed 2018·Granted Jan 14, 2020·0 cites·17 claims
- 3474US2021196814A1Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncytial Virus (RSV) VaccineBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 3572US10946089B2Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccineBAVARIAN NORDIC AS·Filed 2020·Granted Mar 16, 2021·0 cites·18 claims
- 3669US10124058B2Recombinant modified vaccinia virus Ankara (MVA) Respiratory Syncytial Virus (RSV) vaccineBAVARIAN NORDIC AS·Filed 2017·Granted Nov 13, 2018·0 cites·18 claims
- 3769US2012328650A1Modified vaccinia ankara virus variantCHAPLIN PAUL·Filed 2012·Application pending·0 cites
- 3868US9480738B2Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccineBAVARIAN NORDIC AS·Filed 2013·Granted Nov 1, 2016·0 cites·17 claims
- 3966US2011142877A1Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agentsCHAPLIN PAUL·Filed 2007·Application pending·0 cites
- 4062US9717787B2Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccineBAVARIAN NORDIC AS·Filed 2016·Granted Aug 1, 2017·0 cites·22 claims
- 4156US2010011451A1Phenotypic and genotypic differences of mva strainsCHAPLIN PAUL·Filed 2007·Application pending·0 cites
- 4256US2006127984A1Modified Vaccinia virus Ankara for the vaccination of neonatesBAVARIAN NORDIC AS·Filed 2006·Application pending·0 cites
- 4355US9707291B2Single high dose of MVA induces a protective immune response in neonates and infantsBAVARIAN NORDIC AS·Filed 2014·Granted Jul 18, 2017·0 cites·22 claims
- 4455US2011172407A1Phenotypic and genotypic differences of mva strainsCHAPLIN PAUL·Filed 2011·Application pending·0 cites
- 4553US2012183574A1Modified vaccinia virus ankara for the vaccnation of neonatesCHAPLIN PAUL·Filed 2012·Application pending·0 cites
- 4652US2011052627A1Recombinant modified vaccinia virus measles vaccineCHAPLIN PAUL·Filed 2009·Application pending·0 cites
- 4749US10111946B2Poxviral vectors for low antibody response after a first priming immunizationBAVARIAN NORDIC AS·Filed 2013·Granted Oct 30, 2018·0 cites·17 claims
- 4843US2012135032A1Generation of a broad t-cell response in humans against hivCHAPLIN PAUL·Filed 2010·Application pending·0 cites
- 4942US2017081642A1Recombinant poxvirus vector comprising tetanus toxin fragment cBAVARIAN NORDIC AS·Filed 2016·Application pending·0 cites
- 5040US5471902ATuning system for pianosATHENRY ENTERPRISES LIMITED·Filed 1994·Granted Dec 5, 1995·9 cites·13 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →